BIAF
Price
$0.24
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
7.07M
67 days until earnings call
PXMBF
Price
$3.50
Change
+$0.70 (+25.00%)
Updated
May 16 closing price
Capitalization
191.86M
Interact to see
Advertisement

BIAF vs PXMBF

Header iconBIAF vs PXMBF Comparison
Open Charts BIAF vs PXMBFBanner chart's image
bioAffinity Technologies
Price$0.24
Change-$0.00 (-0.00%)
Volume$96.12K
Capitalization7.07M
PAXMAN AB
Price$3.50
Change+$0.70 (+25.00%)
Volume$600
Capitalization191.86M
BIAF vs PXMBF Comparison Chart in %
Loading...
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIAF vs. PXMBF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIAF is a Hold and PXMBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (BIAF: $0.24 vs. PXMBF: $3.50)
Brand notoriety: BIAF and PXMBF are both not notable
BIAF represents the Medical Specialties, while PXMBF is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BIAF: 8% vs. PXMBF: 100%
Market capitalization -- BIAF: $7.07M vs. PXMBF: $191.86M
BIAF [@Medical Specialties] is valued at $7.07M. PXMBF’s [@Medical/Nursing Services] market capitalization is $191.86M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIAF’s FA Score shows that 1 FA rating(s) are green whilePXMBF’s FA Score has 0 green FA rating(s).

  • BIAF’s FA Score: 1 green, 4 red.
  • PXMBF’s FA Score: 0 green, 5 red.
According to our system of comparison, BIAF is a better buy in the long-term than PXMBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIAF’s TA Score shows that 5 TA indicator(s) are bullish.

  • BIAF’s TA Score: 5 bullish, 4 bearish.

Price Growth

BIAF (@Medical Specialties) experienced а -1.28% price change this week, while PXMBF (@Medical/Nursing Services) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.04%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +24.44%.

Reported Earning Dates

BIAF is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PXMBF($192M) has a higher market cap than BIAF($7.07M). PXMBF YTD gains are higher at: 0.000 vs. BIAF (-73.736). PXMBF has higher annual earnings (EBITDA): 57.5M vs. BIAF (-11M). PXMBF has more cash in the bank: 153M vs. BIAF (803K). BIAF has less debt than PXMBF: BIAF (670K) vs PXMBF (9.54M). PXMBF has higher revenues than BIAF: PXMBF (262M) vs BIAF (7.68M).
BIAFPXMBFBIAF / PXMBF
Capitalization7.07M192M4%
EBITDA-11M57.5M-19%
Gain YTD-73.7360.000-
P/E RatioN/A29.27-
Revenue7.68M262M3%
Total Cash803K153M1%
Total Debt670K9.54M7%
FUNDAMENTALS RATINGS
PXMBF: Fundamental Ratings
PXMBF
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
68
PRICE GROWTH RATING
1..100
71
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIAFPXMBF
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
9%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
9%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BIAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYEUX118.670.03
+0.03%
Rydex Europe 1.25x Strategy H
CGACX11.86N/A
N/A
Calvert Global Energy Solutions C
AQGIX12.75N/A
N/A
AQR Global Equity I
ANOGX24.41N/A
N/A
American Century Small Cap Growth R5
HAVLX23.53-0.05
-0.21%
Harbor Large Cap Value Instl

BIAF and

Correlation & Price change

A.I.dvisor tells us that BIAF and SNWV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIAF and SNWV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIAF
1D Price
Change %
BIAF100%
-0.08%
SNWV - BIAF
32%
Poorly correlated
-1.97%
HSCS - BIAF
29%
Poorly correlated
N/A
RDNT - BIAF
26%
Poorly correlated
-1.23%
AORT - BIAF
22%
Poorly correlated
-1.23%
TCMD - BIAF
21%
Poorly correlated
+0.30%
More

PXMBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PXMBF has been loosely correlated with IDTA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PXMBF jumps, then IDTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXMBF
1D Price
Change %
PXMBF100%
N/A
IDTA - PXMBF
53%
Loosely correlated
N/A
ANSLF - PXMBF
37%
Loosely correlated
N/A
IOBCF - PXMBF
30%
Poorly correlated
N/A
BLOZF - PXMBF
24%
Poorly correlated
-0.45%
BIAF - PXMBF
20%
Poorly correlated
-0.08%
More